Steven Cohen Jazz Pharmaceuticals PLC Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 173,870 shares of JAZZ stock, worth $19.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
173,870
Previous 173,870
-0.0%
Holding current value
$19.4 Million
Previous $21.6 Million
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
23 transactions
Others Institutions Holding JAZZ
# of Institutions
582Shares Held
60.2MCall Options Held
424KPut Options Held
192K-
Black Rock Inc. New York, NY6.15MShares$684 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$670 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$274 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$259 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$219 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.98B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...